Anti-Human HER2/neu Recombinant Antibody scFv Fragment (C6.5) (CAT#: TAB-040CT-S(P))

Recombinant monoclonal antibody to HER2/neu. This antibody intended for the prophylaxis and treatment of HER2-positive breast cancer.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FC

Figure 1 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

Figure 1 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

Flow cytometry shows that pretreatment of SK-OV-3 and BT-474 cells with the anti-HER2 mAb trastuzumab does not block binding of the C6.5db to cells as compared with those pretreated with the anti-CD20 mAb rituximab.

Reddy, S., Shaller, C. C., Doss, M., Shchaveleva, I., Marks, J. D., Jian, Q. Y., & Robinson, M. K. (2011). Evaluation of the anti-HER2 C6. 5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Clinical Cancer Research, 17(6), 1509-1520.

IP

Figure 2 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

Figure 2 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

HER2 ECD-coupled agarose beads pretreated with saturating amount of trastuzumab precipitate C6.5db to equal levels as beads pretreated with either rituximab or PBS.

Reddy, S., Shaller, C. C., Doss, M., Shchaveleva, I., Marks, J. D., Jian, Q. Y., & Robinson, M. K. (2011). Evaluation of the anti-HER2 C6. 5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Clinical Cancer Research, 17(6), 1509-1520.

Block

Figure 3 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

Figure 3 C6.5db does not compete with trastuzumab for binding to HER2 in vitro.

Pretreating SK-OV-3 and BT-474 cells with either pertuzumab (D) or C6.5db (E) blocks the ability of the other antibody to bind to the cells. Shaded histogram, no primary antibody. DB, C6.5db; R, rituximab; T, trastuzumab; P, pertuzumab.

Reddy, S., Shaller, C. C., Doss, M., Shchaveleva, I., Marks, J. D., Jian, Q. Y., & Robinson, M. K. (2011). Evaluation of the anti-HER2 C6. 5 diabody as a PET radiotracer to monitor HER2 status and predict response to trastuzumab treatment. Clinical Cancer Research, 17(6), 1509-1520.


Specifications

  • Host Species
  • Human
  • Derivation
  • Phage display library
  • Type
  • Human antibody
  • Specificity
  • Human
  • Species Reactivity
  • Human
  • Clone
  • C6.5
  • Applications
  • FC, IP, Block
  • Related Disease
  • HER2-positive breast cancer

Applications

  • Application Notes
  • The HER2/neu antibody has been reported in applications of Flow Cytometry, Immunoprecipitation, Block.

Target

  • Alternative Names
  • ERBB2; erb-b2 receptor tyrosine kinase 2; NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu; receptor tyrosine-protein kinase erbB-2; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2; metastatic lymph node gene 19 protein; human epidermal growth factor receptor 2; neuro/glioblastoma derived oncogene homolog; tyrosine kinase-type cell surface receptor HER2; neuroblastoma/glioblastoma derived oncogene homolog; v-erb-b2 avian erythroblastic leukemia viral oncoprotein 2; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog;

Related Resources

  • Related Diseases
  • Related Signaling Pathways

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone C6.5"

See other products for "ERBB2"

Select a product category from the dropdown menu below to view related products.
Please select product type
Intrabody Products Chimeric Antibody Products Immunotoxin Products ScFv Antibody Products Human Antibody Products Humanized Antibody Products Mouse Antibody Products Single Domain Antibody Products Fab Glycosylation Antibody Products Fc Glycosylation Antibody Products Deglycosylated Antibody Products IgG Antibody Products Chicken IgY Antibody Products MHC Tetramer Products for Cancer Blocking Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products Antibody Magnetic Beads ScFv-Fc Chimera Products Flow Cytometry (FC) related Reagents and Kits: Empowering Cell Function Research Extracellular Vesicle (EV) Antibody Products
CAT Product Name Application Type
IAB-B008(A) Recombinant Anti-human ERBB2 Intrabody [(D-Arg)9] IF, FC, FuncS scFv-(D-Arg)9
IAB-B008(G) Recombinant Anti-human ERBB2 Intrabody [+36 GFP] WB, ICC, FuncS scFv-(+36GFP)
IAB-B008(T) Recombinant Anti-human ERBB2 Intrabody [Tat] ICC, Neut, FuncS scFv-Tat

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-040CT-S(P). Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare